Skip to content
Nectome logo

Nectome

Nectome is a YC Winter 2018 (W18) company. Based in South San Francisco, CA, USA. Team of 5.

  • Neurotechnology

About Nectome

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Nectome develops whole-body human preservation technology targeting people at the end of life. The process preserves the brain, including its neurons and synaptic connections, to a quality sufficient for tracing the full connectome, replacing the absence of any option beyond standard end-of-life care. The long-term goal is a preserved state detailed enough to make future revival theoretically possible.

From the Y Combinator listing

How Nectome describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Building a way to preserve long-term memories.

Nectome is a neuroscience startup that aims to preserve the brain and keep all its memories intact. The company is building the next generation of tools to preserve the connectome. The connectome is all the connections called synapses between neurons in the brain. Researchers from the company is now learning to manipulate individual memories, building advanced brain prosthetics, and reverse-engineering the brain.

Facts

Industry
Healthcare / Healthcare -> Therapeutics
Location
South San Francisco, CA, USA
Team size
5
Status
Active
Stage
Early

Founders (1)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works